Ocular Therapeutix公司 OCUL 深 沪
已收盘 01-09 16:00:00 美东时间
11.26
-0.120
-1.05%
华盛通- 最 高11.57
- 今 开11.41
- 成交量 266.20万股
- 最 低 11.14
- 昨 收 11.38
- 总市值 23.87亿
- 52周最高 16.44
- 市盈率 静 --
- 换手率 1.26%
- 52周最低 5.785
- 委 比 -86.03%
- 总股本 2.12亿
- 历史最高 44.19
- 量 比 0.94
- 振 幅 3.78%
- 历史最低 1.995
- 每 手 1
- 风险率 2.33%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
01-02 01:35
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
2025-12-10 10:33
美股牛股 | “减肥神药”临床数据引爆！WaVe生命科学涨超147%，硕迪生物涨超102%；Confluent涨超29%
“减肥神药”临床数据引爆！WaVe生命科学涨超147%，硕迪生物涨超102%；Confluent涨超29%，IBM拟110亿美元收购该公司>>
2025-12-09 17:40
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
2025-12-09 10:32
HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Raises Price Target to $21
HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $19 to $21.
2025-12-08 20:34
Why Confluent Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Shares of Confluent Inc (NASDAQ:CFLT) rose sharply in pre-market trading. Inter...
2025-12-08 18:26
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
2025-11-26 10:07
Ocular Therapeutix Begins Major Trial On Drug That Could Prevent Blindness In Working-Age Diabetics
Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular"))), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that the first patient has been randomized in the HELIOS-3 Phase
2025-11-24 20:12
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
2025-11-06 09:55
Ocular Therapeutix Q3 EPS $(0.38) Misses $(0.37) Estimate, Sales $14.544M Miss $14.627M Estimate
Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.37) by 3.54 percent. This is a 72.73 percent decrease over losses of $(0.22) per share
2025-11-04 20:06
